A Father’s Fight for Time: Serdar’s Unwavering Hope
At 45, Serdar Ferit carries a weight few can imagine. A loving father to his 12-year-old son, Jaxon, he is engaged in a relentless race against time, battling stage 4 colon cancer after exhausting his treatment options within the UK’s National Health Service (NHS). Confronting a prognosis that offers a mere 10% chance of surviving five years, Serdar’s world now revolves around a single, profound goal: to prolong his life and stay beside his little boy. His journey is not just a medical struggle, but a deeply human story of love, vulnerability, and a fierce determination to defy statistics.
The most heart-wrenching chapter of this battle began not in a hospital, but on a quiet green behind a local church. Serdar recalls the moment he had to tell his eight-year-old son about his diagnosis as the hardest thing he has ever done. After a gentle explanation, Jaxon’s immediate question—“Do you have cancer?”—was met with a heartbreaking affirmation. The boy burst into tears, inconsolable, grappling with a fear too large for a child: “You’re going to be OK, right? You’re not going to die?” Serdar describes the agony of being unable to offer the simple reassurance every parent wishes to give, the crushing reality of his predicament colliding with his son’s innocent hope.
Serdar’s path to this point was marked by delayed awareness and devastating timing. Initially dismissing symptoms, he finally underwent a colonoscopy in September 2022 only to discover it was “too late.” The cancer was already at stage 4, having spread to his liver and lungs. The shock of the diagnosis was compounded by the cold clarity of online research, revealing the stark five-year survival rate. Since then, his life has been a gruelling cycle of over 30 chemotherapy infusions, 28 sessions of radiotherapy that left him unable to sit, and painful ablation procedures on his lungs and liver. Each treatment was a step in a marathon where the finish line—a cure—remains out of sight.
Currently, chemotherapy and targeted therapy are holding seven small tumours in his lungs stable, but this is a management strategy, not a solution. In mid-2023, Serdar received the crushing news that the cancer would likely adapt and become resistant to these treatments over time. With NHS options exhausted, his search for hope has turned outward. He has now focused his energies on a personalized immunotherapy program offered by a clinic in Mexico—a two-year plan involving advanced treatments like CAR-T therapy, cancer vaccines, and monoclonal antibodies. This approach aims to empower his own immune system to fight the cancer persistently, a potential key to unlocking more time.
The financial barrier to this lifeline is formidable. Serdar estimates the total cost for travel, treatment, and insurance at £290,000. Driven by his love for Jaxon and his aging parents, he has launched a fundraising campaign, already receiving an overwhelming and heartening £97,000 in support. The generosity has been a beacon of light, arriving on a day marked by personal emotional hardship—the signing of his divorce papers. This communal support fuels his resolve, not just to survive, but to thrive and witness his son grow from a boy into a young man.
Despite the physical pain and emotional toll, Serdar describes himself as “one of the happiest stage 4 cancer patients in the world.” His perspective has shifted dramatically; he embraces joy, says “yes” to experiences, and cherishes life with fierce intentionality. He is now three-and-a-half years into his journey, and he genuinely believes he will be among the 10% who survive beyond five years. His fight is more than a medical campaign; it is a testament to the power of love and optimism. For Serdar, every day is a precious opportunity to be here for his son, to support his parents, and to live fully in a world he finds increasingly beautiful, despite its messiness. His race against time is, ultimately, a run toward life.
